The White House on May 5, 2025 issued an executive order requiring the US Food and Drug Administration to find ways to facilitate the opening of ...

Attributing manufacturing problems to “human error” is an oversimplification that can mask deeper failures, according to Ann Ryan, head of business development at Ireland-based training and technology ...

In the pharma industry, key opinion leaders (KOLs ... and webinars aimed at educating doctors on drug development and related subjects. Such initiatives may help find unanswered questions ...

The pharmaceutical construction industry has seen explosive growth ... Every aspect of the design and build process must ensure safety, sterility, and compliance with regulatory frameworks.

Q1 2025 Earnings Call Transcript May 13, 2025 Eton Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

Zhong Li’s extensive history with the FDA offers crucial lessons on how companies in the pharmaceutical and biopharmaceutical sectors should approach inspection preparedness.  As an experienced FDA ...

We appreciate our business is quite different from others in our industry ... of the process, we actually do have like some pretty good visibility. Now that said, there can be slight deviations ...

Additionally, as part of the development environmental licensing process for the Sirius discovery ... with 40% of the impact related to exogenous factors such as falling prices, exchange rate ...

By prioritizing quality, providers reduce the risk of delays and deviations while enabling faster decision ... Praxis is built to serve the pharmaceutical industry, with capabilities in primary ...

Increasing the value of an estate can’t justify violating a sale procedures order in a bankruptcy proceeding, as the integrity of the auction process and adherence ... fairness and transparency, even ...